Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 271.25
-13.95 (-4.89%)
Nov 5, 2026, 5:00 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.2 trillion as of November 5, 2026. It is the 103rd most valuable company in the world and the biggest in Denmark. Its market cap has decreased by 14.61% in one year.
Market Cap
1.20T
Enterprise Value
1.28T
Revenue
333.65B
Global Rank
Country Rank
#1 Denmark
PE Ratio
10.64
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.20T, an increase of 2,499.89%. That is a compound annual growth rate of 11.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 1.20T | -17.25% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 220.97B |
| Coloplast | 108.40B |
| Demant | 77.91B |
| ALK-Abelló | 54.40B |
| H. Lundbeck | 52.78B |
| Ambu A/S | 21.34B |
| Bavarian Nordic | 19.02B |
| Zealand Pharma | 15.77B |